Saturday, June 13, 2026

North Korea’s Kim Yo-jong Calls for Measures Against Drone Incursions: What’s Next?

Kim Yo-jong commended South Korea's regret over a drone incident but stressed the need for concrete measures to prevent future violations.

South Korea’s Elderly Poverty Rate Continues to Climb, Exceeding OECD Averages

Elderly poverty in South Korea has risen to 38.2%, with women facing higher rates than men, highlighting severe income inequality.

From Nazi Allegations to Global Acclaim: Herbert von Karajan’s Musical Legacy Lives On

Herbert von Karajan passed away on July 16, 1937. He remains one of the most influential conductors of the 20th century.

Tag: Alteogen

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Top News

- Our Sponsors Ad -

Follow us